Cancer

New T-cell therapy for KRAS G12D cancers

An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.

New pancreatic cancer treatment option after chemo

A new oral therapy is available for metastatic pancreatic cancer that has progressed after chemotherapy.

Guiding Patients from Cancer Diagnosis through Survivorship

At Providence St. Joseph Hospital Eureka, cancer care extends far beyond diagnosis and treatment.

Precision treatment for prostate cancer with MRI-guided radiation therapy

Advanced imaging technology allows clinicians to deliver targeted prostate cancer treatment while helping protect healthy tissue and reduce side effects. Dr. Amar Srivastava describes what's new.

When standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer

A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.

One Day at a Time: Samantha's Journey Through Metastatic Melanoma

After being diagnosed with mmelanoma while in nursing school and facing a recurrence more than a decade later, Samantha Ybaro continues to move forward with resilience, gratitude and a message of hope

Hope comes in a clinical trial: Brad’s remarkable story

When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.

Back on the Dance Floor: How Targeted Therapy Helped Gene Keep Moving

After his prostate cancer progressed despite treatment, Gene found new possibilities through Pluvicto, an innovative radioligand therapy.

Colonoscopies finding a high rate of early onset colorectal cancer, Providence study finds

Providence researchers head to Chicago for leading cancer conference

Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.

Adoptive cell therapy: Phase III study open for people with advanced melanoma

Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.

It started with one bandage, and a patient’s smile

How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

New guidelines for treating head and neck cancer could be a game changer

New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.

New Providence study identifies provider-patient relationships as central to colorectal cancer screening disparities

A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.

Providence receives esteemed NIH grant for ‘paradigm shift’ in head and neck cancer treatments

Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.

Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

VOICES of Black Women: A community study in cancer prevention and care

A new study focused on stories will change health outcomes for Black women.

Leading the way: Providence researchers at AACR Annual Meeting

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

Treatment options, time, and hope for one family's "chief memory maker"

After Virginia Kuo was diagnosed with lung cancer, Providence Swedish experts were committed to helping this mom of three have the life she envisioned with her husband and family. Learn more